Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.78), $0.12 better than the analyst estimate of ($1.90). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $10.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.